TerminatedPhase 3NCT00927732

Hydroquinidine Versus Placebo in Patients With Brugada Syndrome

Studying Brugada syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nantes University Hospital
Principal Investigator
V Probst, Pr
CHU NANTES - Hôpital Laennec
Intervention
hydroquinidine(drug)
Enrollment
64 enrolled
Eligibility
18 years · All sexes
Timeline
20092014

Study locations (17)

Collaborators

Sanofi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00927732 on ClinicalTrials.gov

Other trials for Brugada syndrome

Additional recruiting or active studies for the same condition.

See all trials for Brugada syndrome

← Back to all trials